Delivery Order SPE2DB22D1106-SPE2DB25FEZP9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This contract is valued at $2,284.62 under a firm fixed-price delivery order arrangement with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,184.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $1,570.10, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 5, 2025. The contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,161.00 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZP9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,941.60 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of OxyContin ER 15 mg tablets in quantities of 100 units. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The vendor's substantial contract portfolio with the Defense Logistics Agency demonstrates its established capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/24/25 |